Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA

NCT06424639 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia

Interventions

DRUG: Luspatercept
DRUG: cyclosporine

Sponsor

Peking Union Medical College Hospital